Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984920791> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W1984920791 abstract "Purpose To evaluate the feasibility and activity of a second line chemotherapy regimen consisting of VP16, mitoxantrone and prednimustine (VMP) in patients with relapsed or resistant HIV related non-Hodgkin's lymphoma (HIV-NHL). Patients and methods Twenty-one patients were consecutively treated Thirteen patients were resistant to primary chemotherapy and eight patients had relapsed after first complete remission (CR). VP16 and prednimustine were both given orally at doses of 80 mg/m 2 daily for 5 days, and mitoxantrone was given i.v. at a dose of 10 mg/m 2 on day 1; cycles were repeated every three weeks. Results Nineteen out of 21 patients are evaluable for response. The median number of cycles actually administered was 2 (range 1–5). A CR occurred in 5 out of 19 patients (26%; exact 95% confidence interval: 9% to 51%). Four of these CRs were observed in the 7 evaluable relapsed patients. Out of 45 cycles evaluable for toxicity, severe neutropenia ( Conclusion Although the overall prognosis of patients with resistant and relapsed HIV-NHL is very poor, palliative therapy with VMP can be effective and relatively safe. Prolonged survivals have been observed in some patients who had relapsed after initial chemotherapy. Supported by AIRC 95 grants." @default.
- W1984920791 created "2016-06-24" @default.
- W1984920791 creator A5012692118 @default.
- W1984920791 creator A5020913131 @default.
- W1984920791 creator A5021793394 @default.
- W1984920791 creator A5033302656 @default.
- W1984920791 creator A5038699632 @default.
- W1984920791 creator A5046311100 @default.
- W1984920791 creator A5051976240 @default.
- W1984920791 creator A5081879832 @default.
- W1984920791 creator A5085445811 @default.
- W1984920791 date "1996-01-01" @default.
- W1984920791 modified "2023-09-26" @default.
- W1984920791 title "179 P - Second line chemotherapy in HIV-related non-hodgkin's lymphoma: Evidence of activity of a combination of VP16, mitoxantrone and prednimustine in relapsed patients" @default.
- W1984920791 doi "https://doi.org/10.1016/0959-8049(96)84934-3" @default.
- W1984920791 hasPublicationYear "1996" @default.
- W1984920791 type Work @default.
- W1984920791 sameAs 1984920791 @default.
- W1984920791 citedByCount "0" @default.
- W1984920791 crossrefType "journal-article" @default.
- W1984920791 hasAuthorship W1984920791A5012692118 @default.
- W1984920791 hasAuthorship W1984920791A5020913131 @default.
- W1984920791 hasAuthorship W1984920791A5021793394 @default.
- W1984920791 hasAuthorship W1984920791A5033302656 @default.
- W1984920791 hasAuthorship W1984920791A5038699632 @default.
- W1984920791 hasAuthorship W1984920791A5046311100 @default.
- W1984920791 hasAuthorship W1984920791A5051976240 @default.
- W1984920791 hasAuthorship W1984920791A5081879832 @default.
- W1984920791 hasAuthorship W1984920791A5085445811 @default.
- W1984920791 hasConcept C126322002 @default.
- W1984920791 hasConcept C141071460 @default.
- W1984920791 hasConcept C2776694085 @default.
- W1984920791 hasConcept C2777063308 @default.
- W1984920791 hasConcept C2778476748 @default.
- W1984920791 hasConcept C2779338263 @default.
- W1984920791 hasConcept C2780923524 @default.
- W1984920791 hasConcept C2781413609 @default.
- W1984920791 hasConcept C71924100 @default.
- W1984920791 hasConcept C90924648 @default.
- W1984920791 hasConceptScore W1984920791C126322002 @default.
- W1984920791 hasConceptScore W1984920791C141071460 @default.
- W1984920791 hasConceptScore W1984920791C2776694085 @default.
- W1984920791 hasConceptScore W1984920791C2777063308 @default.
- W1984920791 hasConceptScore W1984920791C2778476748 @default.
- W1984920791 hasConceptScore W1984920791C2779338263 @default.
- W1984920791 hasConceptScore W1984920791C2780923524 @default.
- W1984920791 hasConceptScore W1984920791C2781413609 @default.
- W1984920791 hasConceptScore W1984920791C71924100 @default.
- W1984920791 hasConceptScore W1984920791C90924648 @default.
- W1984920791 hasLocation W19849207911 @default.
- W1984920791 hasOpenAccess W1984920791 @default.
- W1984920791 hasPrimaryLocation W19849207911 @default.
- W1984920791 hasRelatedWork W1970679165 @default.
- W1984920791 hasRelatedWork W2017258111 @default.
- W1984920791 hasRelatedWork W2057206793 @default.
- W1984920791 hasRelatedWork W2077485687 @default.
- W1984920791 hasRelatedWork W2081122523 @default.
- W1984920791 hasRelatedWork W2133743721 @default.
- W1984920791 hasRelatedWork W2143606915 @default.
- W1984920791 hasRelatedWork W2152759295 @default.
- W1984920791 hasRelatedWork W2156203592 @default.
- W1984920791 hasRelatedWork W2257495951 @default.
- W1984920791 hasRelatedWork W2386817084 @default.
- W1984920791 hasRelatedWork W2418513167 @default.
- W1984920791 hasRelatedWork W2465395853 @default.
- W1984920791 hasRelatedWork W2549408207 @default.
- W1984920791 hasRelatedWork W2555250317 @default.
- W1984920791 hasRelatedWork W2593974334 @default.
- W1984920791 hasRelatedWork W2968223450 @default.
- W1984920791 hasRelatedWork W3000628660 @default.
- W1984920791 hasRelatedWork W3170368665 @default.
- W1984920791 hasRelatedWork W38767550 @default.
- W1984920791 isParatext "false" @default.
- W1984920791 isRetracted "false" @default.
- W1984920791 magId "1984920791" @default.
- W1984920791 workType "article" @default.